The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Prof. Max E. Scheulen

Prof. Max E. Scheulen 

He is Hematologist and Medical Oncologist as well as Biochemist and Toxicologist by training and currently Professor of Internal Medicine and Leader of the Clinical Phase I-Unit of the Department of Internal Medicine (Cancer Research) at the West German Cancer Center (WGCC) at the University Hospital of Essen.

He has established the Clinical Phase I-Unit as well as the Laboratory for the Pharmacology of Antineoplastic Drugs (LPhAD) at the WGCC in Essen.

He is founding member oft he Central European Society for Anticancer Drug Research (CESAR-EWIV) in 2000 of which he was President from 2005 until 2009.

In addition, he has published more than 110 papers in peer-reviewed scientific journals and has chaired numerous international scientific meetings.

Research Interests

  • Early Clinical Drug Development
  • Translational Research
  •  Identification of Biomarkers and Surrogate Markers
  •  Mechanisms of Drug Resistance

Contact Prof. Max E. Scheulen

Cancer Drug Development Forum
c/o BLSI
Clos Chapelle-aux-Champs 30
1200 Brussels, Belgium
Tel: +32 2 880 62 70

Legal address
c/o Deloitte Tirol
Wirtschaftsprüfungs GmbH,
Wilhelm-Greil-Str. 15,
6020 Innsbruck, Austria